Filing Details
- Accession Number:
- 0001127602-20-014583
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-27 18:55:23
- Reporting Period:
- 2020-04-24
- Accepted Time:
- 2020-04-27 18:55:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 97745 | Thermo Fisher Scientific Inc. | TMO | Measuring & Controlling Devices, Nec (3829) | 042209186 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1387890 | Mark Stevenson | 168 Third Avenue Waltham MA 02451 | Executive Vice President & Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-04-24 | 25,000 | $124.28 | 73,538 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-04-24 | 800 | $324.55 | 72,738 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-24 | 1,533 | $325.76 | 71,205 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-24 | 1,690 | $326.88 | 69,515 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-24 | 7,468 | $327.85 | 62,047 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-24 | 13,509 | $328.73 | 48,538 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-04-24 | 25,000 | $0.00 | 25,000 | $124.28 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 50,000 | 2021-02-26 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 477 | Indirect | By 401(k) |
| Common Stock | 53,959 | Indirect | By Stevenson 2010 Living Trust |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2020.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $324.28 to $325.035, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5) and (6) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $325.285 to $326.28, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $326.32 to $327.29, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $327.33 to $328.29, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $328.35 to $329.11, inclusive.
- The option vested in four equal installments on February 26, 2015, 2016, 2017, and 2018.
Billionaire Hedge Funds
